These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13837261)

  • 21. Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.
    GREEN H; ERICKSON RW
    J Pharmacol Exp Ther; 1960 Jul; 129():237-42. PubMed ID: 13851486
    [No Abstract]   [Full Text] [Related]  

  • 22. A clinical trial of an antidepressant, tranylcy-promine ("Parnate").
    KINGSTON WR
    Med J Aust; 1962 Jun; 49(1)():1011-2. PubMed ID: 14456153
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 24. 2-SUBSTITUTED CYCLOPROPYLAMINES. II. EFFECT OF STRUCTURE UPON MONOAMINE OXIDASE-INHIBITORY ACTIVITY AS MEASURED IN VIVO BY POTENTIATION OF TRYPTAMINE CONVULSIONS.
    ZIRKLE CL; KAISER C; TEDESCHI DH; TEDESCHI RE; BURGER A
    J Med Pharm Chem; 1962 Nov; 5():1265-84. PubMed ID: 14056459
    [No Abstract]   [Full Text] [Related]  

  • 25. 3-Phenylcyclobutylamine.
    BURGER A; BENNETT R
    J Med Pharm Chem; 1960 Dec; 2():687-91. PubMed ID: 13688995
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
    GENOVESE E; ARRIGONI-MARTELLI E; FRESIA P
    Farmaco Sci; 1959 Jul; 14():516-26. PubMed ID: 13849925
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological treatment of depressive states with a new monoamine oxidase antagonist].
    ANDERSON M
    Minerva Med; 1959 Dec; 50():4461-8. PubMed ID: 13793412
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.
    SHORE PA; COHN VH
    Biochem Pharmacol; 1960 Oct; 5():91-5. PubMed ID: 13912256
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
    Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
    Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 31. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of amine oxidase inhibitors on the conditional psychogalvanic reflex in man.
    ALEXANDER L; LIPSETT SR
    Dis Nerv Syst; 1959 Aug; 20(Suppl)():26-33. PubMed ID: 13792591
    [No Abstract]   [Full Text] [Related]  

  • 33. An unusual reaction to tranylcypromine.
    BROWN DD; WALDRON DH
    Practitioner; 1962 Jul; 189():83-6. PubMed ID: 13873601
    [No Abstract]   [Full Text] [Related]  

  • 34. New inhibitor of monoamine oxidase.
    TAYLOR JD; WYKES AA; GLADISH YC; MARTIN WB
    Nature; 1960 Sep; 187():941-2. PubMed ID: 13775618
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in the intrahepatic circulation and the reticuloendothelial system induced by inhibitors of monoamine oxidase.
    ZWEIFACH BW; CASCARANO J
    Ann N Y Acad Sci; 1959 Sep; 80():939-46. PubMed ID: 13847962
    [No Abstract]   [Full Text] [Related]  

  • 36. Tranylcypromine in the office treatment of depression.
    PELZMAN O
    Psychiatr Q; 1961 Apr; 35():261-7. PubMed ID: 13734049
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic aspects of monoamine oxidase inhibition.
    WEBB JL
    Am J Cardiol; 1960 Dec; 6():1112-6. PubMed ID: 13783566
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preliminary clinical observations on treatment with a monoamine oxidase antagonist in coronary diseases and in other disease states].
    DE RITIS F; ASCIONE A; MATANO F
    Minerva Med; 1959 Dec; 50():4437-41. PubMed ID: 13814985
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoamine oxidase inhibition.
    ROSENBLUM I; FERGUSON FC
    Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinico-therapeutic evaluation of a new inhibitor of monoamine oxidase, nialamide].
    PRATESI G; MUZZOLINI M
    Minerva Med; 1959 Dec; 50():4447-53. PubMed ID: 14434665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.